Clinical Trial Update: A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update showing efficacy and safety results for K-161 Ophthalmic Solution in adults with moderate to severe Dry Eye Disease; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• K-161 Ophthalmic Solution

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-01-14